reverse listing maybe easier, there was a run of those on the Nasdaq for a few ears after 2011 but if they could pull that off, then get FDA approvals or vise versa a significant re-rate wld occur you'd think
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-11
Add to My Watchlist
What is My Watchlist?